Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism (Q37034670)

From Wikidata
Jump to navigation Jump to search
scientific article published on February 2012
edit
Language Label Description Also known as
English
Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism
scientific article published on February 2012

    Statements

    Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism (English)
    Jim C Hu
    Stephen B Williams
    Matthew R Smith
    Paul L Nguyen
    1 February 2012
    1119-1128

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit